Fig. 3

Xylo-oligosaccharide supplementation and arabinoxylan-rich fraction (XOS/AXRF) supplementation reduced intestinal cell migration associated with actin dynamic. Xylo-oligosaccharide and arabinoxylan-rich fraction supplemented at 0.5% and 1% level, respectively. In red, differentially abundant protein (DAP) showing lower abundance in XOS/AXRF supplemented chickens. In green, DAP showing higher abundance in XOS/AXRF supplemented chickens. MYO1A Myosin IA, VIL1 Villin 1, RAC1 Ras-related C3 botulinum toxin substrate 1, ARPC4 Actin-related protein 2/3 complex, subunit 4, COTL1 Coactosin-like F-actin binding protein 1, GSN Gelsolin, CTTN Cortactin, HSPB1 Heat shock protein family B (small) member 1, CAPZA2 Capping actin protein of muscle Z-line alpha subunit 2, DSTN Destrin, actin depolymerizing factor, MYH9 Myosin, heavy chain 9, non-muscle, CDC42 Cell division cycle 42, MYLK Myosin light chain kinase, PAK P21-activated kinase, WASP Wiskott-Aldrich syndrome protein, WAVE WASP family Verprolin-homologous protein, ARP2/3 Actin-related protein 2/3 complex